Dale G. Renlund

TL;DR: It is concluded that longer interval between transplants, accelerated coronary artery disease as cause of allograft loss, and lack of preoperative mechanical assistance are predictive of longer survival after repeat transplantation.

TL;DR: A case of carbon monoxide poisoning that led to severe myocardial damage in the transplanted heart is presented.

TL;DR: Pretransplant characteristics showed that dilated cardiomyopathy was more common in Group 2 patients, and lower cardiac index and ejection fraction were more prevalent in Group 3 patients as expected, and allograft survival and cause of death were not different among the three groups.

TL;DR: The AMPD1 C34T polymorphism influences transplant-free cardiovascular survival in the setting of ischemic left ventricular dysfunction and no benefit was found in the nonischemic group although the number of events was too small to reliably exclude a benefit by genotype.

TL;DR: OkT3 monoclonal antibody (OKT3) has already proved to be a valuable edition to the immunosuppression armamentarium available in cardiac transplantation, but may be even more valuable in prophylaxis, where in combination with an antibody suppression strategy and low-dose, "delayed" cyclosporine it appears to afford near complete protection against rejection.